Peter Rasmussen, MD

Appointed
1998

Education & Fellowships

Fellowship - Cleveland Clinic
Interventional Neuroradiology
Cleveland, OH USA
2000

Fellowship - Cleveland Clinic
Cerebrovascular Neurosurgery
Cleveland, OH USA
1999

Residency - University of Wisconsin Hospital and Clinics
Neurological Surgery
Madison, WI USA
1998

Internship - University of Wisconsin Hospital and Clinics
General Surgery
Madison, WI USA
1992

Medical Education - University of Wisconsin Medical School
MD
Madison, WI USA
1991

Undergraduate - University of Wisconsin-Madison
Madison, WI USA
1987

Additional Training

• Gamma Knife® certification
• Gamma Knife® Perfexion™
• American Board of Neurological Surgery
• AAHRPP Human Subjects Protection Education Program

Professional Highlights

• Past Vice-Chair Joint Section of Cerebrovascular Surgery
• Past President, Society of Neurointerventional Surgery

Certifications

• Neurological Surgery

Specialty Interests

AVMs, brain aneurysm, carotid and intracranial angioplasty and stenting, Carotid Artery Disease, Carotid Artery Stenosis, Carotid Endarterectomy, Carotid Stenting, Cerebral Aneurysms, Cerebrovascular Disease, cerebrovascular disease including AVMs and intracranial aneurysms, dural AV fistulas, endovascular and microsurgical management of cerebral aneurysms, endovascular and microsurgical treatment of cerebral aneurysms and vascular malformations, endovascular treatment of stroke and intracranial occlusive disease, epistaxis, fistulas, Hemorrhagic Stroke, intracranial stenosis, ischemic stroke, pre-operative tumor embolization, spinal AVM's, spinal cord vascular malformations, spinal vascular malformations, stenting and surgical treatment of carotid disease, Stroke, treatment of spinal cord vascular lesions, vascular malformations

Awards & Honors

• Young Neurosurgical Investigator Award, Bayer Corporation ($25,000 research grant), 2000
• Neurosurgery “Teacher of the Year” Award, Cleveland Clinic Neurological Institute, 2006-2007
• Best Doctors in America, 2007-2008
• Fellow of the American Heart Association
• Fellow of the American Association of Neurological Surgeons
• Fellow of the Society of Neurointerventional Surgery

Innovations & Patents

• Founder of Cleveland Clinic's Mobile Stroke Treatment Unit

Memberships

• American Association of Neurological Surgeons
• Society of Neurointerventional Surgery
• Joint Sections on Cerebrovascular Surgery/Neurotrauma and Critical Care

See publications for Peter Rasmussen, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 7/12/2023, Dr. Rasmussen has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Rasmussen receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Centerline Biomedical, Inc.

Equity Dr. Rasmussen owns stock or stock options in the following companies for activities as a founder, inventor, discover, developer:

• Mehana Medical, LLC

Fiduciary Role. Dr. Rasmussen serves in a fiduciary capacity, such as an elected officer, director or chief medical officer, for the following companies or other entities:

• Cleveland Clinic American Well Joint Venture, LLC (CCAW JV, LLC)
• Mehana Medical, LLC

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.